
World Tuberculosis (TB) Day, observed annually on March 24, amplifies the urgency of ending tuberculosis, the world’s deadliest infectious disease. TB continues to devastate millions globally, inflicting severe health, social, and economic consequences. The WHO's key messages this year are Commit, Invest, Deliver. Proven WHO-recommended interventions include early detection, diagnosis, preventive treatment, and high-quality TB care, particularly for drug-resistant TB.
DiagCor Life Science offers multiple options for TB testing. The GenoScreen TB qPCR Kit is a sensitive, highly specific kit, compatible with various real time PCR machines to quickly detect Mycobacterium Tuberculosis (MTB) complex in clinical specimens. For antibiotic-resistant MTB, the GenoFlowTM DR-MTB Array Test Kit detects and genotypes tuberculosis variants resistant to rifampicin (RIF) and isoniazid (INH) in liquefied, decontaminated human respiratory specimens.
Please get in touch to learn more.
Acerca de DiagCor
Ubicados en Hong Kong, DiagCor se ha dedicado al desarrollo de pruebas moleculares (MDx) desde el 2006. Como líderes mundiales de la tecnología de hibridación rápida (flow-through hybridization), nuestra compañía ofrece una amplia gama de productos, soluciones y servicios relacionados con el análisis de ADN y ARN. Así mismo proveemos servicios de laboratorio MDx a médicos y profesionales en Asia Pacífica. DiagCor desarrolla y fabrica productos y soluciones MDx y a su vez ofrece consultoría en medicina translacional para proyectos MDx.
Contacto de prensa
DiagCor Life Science